MedPath

Comparative study to see the effects of drug on incidence and severity of post operative sore throat

Not yet recruiting
Conditions
fit and healthy individuals
Registration Number
CTRI/2020/02/023647
Lead Sponsor
Department of anaesthesiology AIIMS Rishikesh
Brief Summary

This study is aimedat assessment of reduction in post-extubation sore throat after administration of study drugs in the cuff of endotracheal tube(ETT) in patients requiring intubation for various surgeries. Dexamethasone in two different doses of 0.1mg/kg,0.2 mg/kg respectively and normal saline will be used as study drugs forinflation of ETT cuff. We will also assess any other complications likehoarseness, dysphonia and airway dysphoria. Other beneficial effects inaddition to reducing airway complications will too be evaluated. The resultscan help us in finding the effectivity of dexamethasone for alleviating POSTand the optimal dose for same. It can further pave way for anaesthetists toconduct studies in patients predisposed to increased airway morbidity likeobese, paediatric, head and neck surgeries, surgeries in prone position etc. 

| |

| --- |

|**Assessment of POST:**

The assessment of sore throat and hoarseness will be done at one hour, 6 hr and 24 hrs post extubation. Scoring system will be as follows:

POST

0        -  no sore throat

1        -  Minimal sore throat

2        -  Moderate sore throat

3        -  Severe sore throat

HOARSENESS

0-      No complaint of hoarseness

1-       Minimal change in quality of speech (minimal hoarseness)

2-      Moderate change in quality of speech (moderate hoarseness)

3-       Gross change in the quality of speech (severe hoarseness)

**Analysis:** Continuous variables will be presented as a mean ±standard deviation. If the values are unevenly distributed, categoricalvariables will be expressed as frequencies (%). Categorical variables will becompared between the groups using the Chi‑squaretest with the Fisher’s exact test where applicable. Continuous variables willbe compared between the groups using analysis of variance. Post‑hoc analysiswould be performed using the Bonferroni test. Value of p < 0.05 would be considered statistically significant. Theanalysis will be done using Statistical Package for the Social Sciencessoftware, Version 21.0 (IBM Corp., Armonk, NY, USA).

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria
  • 1.The population between age group of 18 year to 65 years, weighing 40-80 kg.
  • 2.Patients belonging to ASA I or II.
  • 3.Patients receiving general anaesthesia with endotracheal intubation for elective surgery.
Exclusion Criteria
  • The study will exclude: 1.Patients with history of recent respiratory tract infection or sore throat.
  • 2.History of neuromuscular disease.
  • 3.Duration of tracheal intubation of < 60 min or > 240 min and requiring more than one attempt for tracheal intubation.
  • Preoperative use of analgesics or steroids.
  • History of laryngeal or tracheal surgery or pathology 6.Any patients with diabetes mellitus and obesity will also be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2- Moderate sore throat1 h, 6 h, 24 h
Assessment of POST:1 h, 6 h, 24 h
The assessment of sore throat and hoarseness will be done at one hour, 6 hr and 24 hrs post extubation. Scoring system will be as follows:1 h, 6 h, 24 h
POST1 h, 6 h, 24 h
1- Minimal sore throat1 h, 6 h, 24 h
0- no sore throat1 h, 6 h, 24 h
3- Severe sore throat1 h, 6 h, 24 h
Secondary Outcome Measures
NameTimeMethod
HOARSENESS0-No complaint of hoarseness

Trial Locations

Locations (1)

AIIMS

🇮🇳

Garhwal, UTTARANCHAL, India

AIIMS
🇮🇳Garhwal, UTTARANCHAL, India
Bhavna Gupta
Principal investigator
8527686660
bhavna.kakkar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.